Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,078 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to: Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategy.
Iannalfi A, D'Ippolito E, Riva G, Molinelli S, Gandini S, Viselner G, Fiore MR, Vischioni B, Vitolo V, Bonora M, Ronchi S, Petrucci R, Barcellini A, Mirandola A, Russo S, Vai A, Mastella E, Magro G, Maestri D, Ciocca M, Preda L, Valvo F, Orecchia R. Iannalfi A, et al. Among authors: riva g. Neuro Oncol. 2022 Aug 1;24(8):1402-1403. doi: 10.1093/neuonc/noab255. Neuro Oncol. 2022. PMID: 34850206 Free PMC article. No abstract available.
High-Risk Prostate Cancer and Radiotherapy: The Past and the Future. A Benchmark for a New Mixed Beam Radiotherapy Approach.
Marvaso G, Jereczek-Fossa BA, Riva G, Bassi C, Fodor C, Ciardo D, Cambria R, Pansini F, Zerini D, De Marco P, Cattani F, De Cobelli O, Orecchia R. Marvaso G, et al. Among authors: riva g. Clin Genitourin Cancer. 2017 Jun;15(3):376-383. doi: 10.1016/j.clgc.2017.01.007. Epub 2017 Jan 18. Clin Genitourin Cancer. 2017. PMID: 28190704 Clinical Trial.
Short-term high precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion: ad interim analysis and preliminary results of Phase II trial AIRC-IG-13218.
Timon G, Ciardo D, Bazani A, Marvaso G, Riva G, Volpe S, Rojas DP, Renne G, Petralia G, Zerini D, Fodor C, Dicuonzo S, Maestri D, Pansini F, Cambria R, Cattani F, Golino F, Scroffi V, De Lorenzo D, De Cobelli O, Orecchia R, Jereczek-Fossa BA. Timon G, et al. Among authors: riva g. Br J Radiol. 2018 Sep;91(1089):20160725. doi: 10.1259/bjr.20160725. Epub 2018 May 23. Br J Radiol. 2018. PMID: 29750539 Free PMC article. Clinical Trial.
Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer.
Jereczek-Fossa BA, Maucieri A, Marvaso G, Gandini S, Fodor C, Zerini D, Riva G, Alessandro O, Surgo A, Volpe S, Fanetti G, Arculeo S, Zerella MA, Parisi S, Maisonneuve P, Vavassori A, Cattani F, Cambria R, Garibaldi C, Starzyńska A, Musi G, De Cobelli O, Ferro M, Nolè F, Ciardo D, Orecchia R. Jereczek-Fossa BA, et al. Among authors: riva g. Med Oncol. 2018 Nov 27;36(1):9. doi: 10.1007/s12032-018-1233-1. Med Oncol. 2018. PMID: 30483899
Comparison of Outcomes and Toxicity Between Extreme and Moderate Radiation Therapy Hypofractionation in Localized Prostate Cancer: A Propensity Score Analysis.
Marvaso G, Ciardo D, Gandini S, Riva G, Frigo E, Volpe S, Fodor C, Zerini D, Rojas DP, Comi S, Cambria R, Cattani F, Musi G, De Cobelli O, Orecchia R, Jereczek-Fossa BA. Marvaso G, et al. Among authors: riva g. Int J Radiat Oncol Biol Phys. 2019 Nov 15;105(4):735-744. doi: 10.1016/j.ijrobp.2019.07.027. Epub 2019 Aug 1. Int J Radiat Oncol Biol Phys. 2019. PMID: 31377161
Mould-based surface high-dose-rate brachytherapy for eyelid carcinoma.
Vavassori A, Riva G, Durante S, Fodor C, Comi S, Cambria R, Cattani F, Spadola G, Orecchia R, Jereczek-Fossa BA. Vavassori A, et al. Among authors: riva g. J Contemp Brachytherapy. 2019 Oct;11(5):443-448. doi: 10.5114/jcb.2019.88619. Epub 2019 Oct 30. J Contemp Brachytherapy. 2019. PMID: 31749853 Free PMC article.
1,078 results